Mary Luz Campillo

Mary Luz Campillo is an experienced professional in the field of diagnostic biomarkers and medical affairs, currently serving as the Director of Diagnostic Biomarkers for the International Region at Incyte since January 2023. Previously, Campillo held the position of Associate Director for Diagnostic Biomarker Europe at the same company. Prior experience includes leading Medical Affairs and Business Development for Iberia and Latin America at Guardant Health, and serving as Diagnostic Manager for Oncology at AstraZeneca, where responsibilities included the development and implementation of diagnostic plans. Campillo's career also encompasses roles at QIAGEN as Local Marketing Manager for MDx Iberia, and at Applied Biosystems and Amersham, contributing to marketing and technical support initiatives. Campillo holds a Ph.D. in Molecular Biology from Universidad Autónoma de Madrid, as well as a Master's Degree in Biology from Universidad Complutense de Madrid, complemented by business education from EOI Business School.